Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AdaptHealth (AHCO) EBITDA Margin (2019 - 2025)

AdaptHealth (AHCO) has 7 years of EBITDA Margin data on record, last reported at 2.27% in Q4 2025.

  • For Q4 2025, EBITDA Margin fell 1905.0% year-over-year to 2.27%; the TTM value through Dec 2025 reached 13.94%, down 466.0%, while the annual FY2025 figure was 13.94%, 466.0% down from the prior year.
  • EBITDA Margin reached 2.27% in Q4 2025 per AHCO's latest filing, down from 18.83% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 21.32% in Q4 2024 and bottomed at 46.11% in Q3 2023.
  • Average EBITDA Margin over 5 years is 11.95%, with a median of 17.53% recorded in 2022.
  • Peak YoY movement for EBITDA Margin: crashed -6400bps in 2023, then skyrocketed 6456bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 19.1% in 2021, then dropped by -20bps to 15.25% in 2022, then tumbled by -200bps to 15.26% in 2023, then surged by 240bps to 21.32% in 2024, then tumbled by -89bps to 2.27% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 2.27% in Q4 2025, 18.83% in Q3 2025, and 20.8% in Q2 2025.